Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer

Published:2017-06-16 Issue:9 Volume:16 Page:1999-2007
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Santos Cristina,Azuara Daniel,Garcia-Carbonero Rocio,Alfonso Pilar Garcia,Carrato Alfredo,Elez Mª Elena,Gomez Auxiliadora,Losa Ferran,Montagut Clara,Massuti Bartomeu,Navarro Valenti,Varela Mar,Lopez-Doriga Adriana,Moreno Victor,Valladares Manuel,Manzano Jose Luis,Vieitez Jose Maria,Aranda Enrique,Sanjuan Xavier,Tabernero Josep,Capella Gabriel,Salazar Ramon

Funder

Fondo Europeo de Desarrollo Regional

Instituto de Salud Carlos III

Catalan Health Institute and Autonomous Government of Catalonia DURSI grants

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis;BMC Cancer;2023-11-16

2. Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer;Diagnostics;2021-12-16

3. Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer;Frontiers in Oncology;2020-07-16

4. Consecutive and automatic detection of multi-gene mutations from colorectal cancer samples by coupling droplet array-based capillary electrophoresis and PCR-RFLP;Analytical and Bioanalytical Chemistry;2020-04-06

5. High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases;Clinical Colorectal Cancer;2020-03